Methemoglobinemia in COVID-19

Am J Med Sci. 2021 Aug;362(2):222-224. doi: 10.1016/j.amjms.2021.04.020. Epub 2021 May 10.

Authors

Kamal Kant Sahu¹, Ajay Kumar Mishra², Kundan Mishra³

Affiliations

¹ Department of Hematology and Oncology, Saint Vincent Hospital, Worcester, MA, United States. Electronic address: drkksahu85@gmail.com.
² Department of Internal Medicine, Saint Vincent Hospital, Worcester, MA, United States.
³ Department of Clinical Haematology and Stem Cell Transplant, Army Hospital (Research & Referral), New Delhi, India.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Aged
Antirheumatic Agents / adverse effects
COVID-19 / complications
COVID-19 / diagnosis*
COVID-19 Drug Treatment*
Humans
Hydroxychloroquine / adverse effects*
Male
Methemoglobinemia / chemically induced*
Methemoglobinemia / diagnosis*
Methemoglobinemia / etiology
Middle Aged

Substances

Antirheumatic Agents
Hydroxychloroquine